Gurbakhash N M N Kaur (Gurbakhash Kaur)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

End Stage Renal Disease

Multiple Myeloma

Top Venues

Blood cancer journal

JCO oncology practice

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fieke W Hoff, Rahul Banerjee, Adeel M Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James P Roose, Larry D Anderson, Andrew J Cowan, Sundararajan Vincent Rajkumar, Gurbakhash N M N Kaur
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood cancer journal 14 (1) (2024)
Fieke W Hoff, Rahul Banerjee, Adeel M Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James P Roose, Larry D Anderson, Andrew J Cowan, Sundararajan Vincent Rajkumar, Gurbakhash N M N Kaur
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Fieke W Hoff, Rahul Banerjee, Adeel M Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James P Roose, Larry D Anderson, Andrew J Cowan, Sundararajan Vincent Rajkumar, Gurbakhash N M N Kaur
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Brittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, Noel Estrada-Merly, Lohith Gowda, Gemlyn George, Marcos J deLima, Shahrukh K. Hashmi, Mohamed A Kharfan-Dabaja, Navneet S Majhail, Rahul Banerjee, Ayman Saad, Gerhard C Hildebrandt, Hira Mian, Muhammad Bilal Abid, Minoo Battiwalla, Lazaros J Lekakis, Sagar S Patel, Hemant S Murthy, Yago L Nieto, Christopher S Strouse, Sherif M Badawy, Samer Ai Al Hadidi, Bhagirathbhai R Dholaria, Mahmoud Aljurf, David H Vesole, Cindy H Lee, Attaphol Pawarode, Usama Gergis, Kevin Charles Miller, Leona A Holmberg, Aimaz Afrough, Melhem M Solh, Pashna Munshi, Taiga Nishihori, Larry D Anderson, Baldeep Wirk, Gurbakhash N M N Kaur, Muzaffar H Qazilbash, Nina Shah, Shaji K Kumar, Saad Z Usmani
Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis. Blood advances (2023)
Zhu Cui, Francesco Castagna, Waqas Hanif, Samuel J Apple, Lili Zhang, James M Tauras, Ira Braunschweig, Gurbakhash N M N Kaur, Murali Janakiram, Yanhua Wang, Yanan Fang, Juan Carlos Díaz, Carolina Hoyos, Jorge E Marín, Patricia A Pellikka, Jorge E Romero, Mario J Garcia, Amit K Verma, Nishi Shah, Leandro Slipczuk
Global Longitudinal Strain Is Associated with Mortality in Patients with Multiple Myeloma. Journal of clinical medicine 12 (7) (2023)
Lauren C Peres, Laura B Oswald, Christen M Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J Blue, Ciara Louise Freeman, Frederick L Locke, Melissa Alsina, Omar Castaneda Puglianini, Leyla Shune, Douglas W Sborov, Charlotte B Wagner, Danai Dima, Hamza Hashmi, James A Davis, Mehmet Hakan Kocoglu, Ashraf Z Badros, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher J Ferreri, Larry D Anderson, Aimaz Afrough, Gurbakhash N M N Kaur, Yi Lin, Lawrence Liu, Omar Nadeem, Peter M Voorhees, Jack Khouri, Joseph P McGuirk, Surbhi Sidana, Doris K Hansen, Krina K Patel
Racial and ethnic differences in clinical outcomes among multiple myeloma patients treated with CAR T-cell therapy. Blood advances (2023)
Banu E Symington, Nagla F Abdel Karim, Lara Briseño Kenney, Suzanne M Cole, Melissa A Crawley, Gurbakhash N M N Kaur, Jessica E Sullivan
Who Should Be Responsible for Relief of Financial Toxicity? JCO oncology practice 18 (4) (2022)
Gurbakhash N M N Kaur, Murali Janakiram
B7x-from bench to bedside. ESMO open 4 (5) (2019)